Joel Greenblatt's HCA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 23,615 shares of HCA Healthcare, Inc. (HCA) worth $10.06 M, representing 0.04% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in HCA, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2016, adding 374,893 shares. Largest reduction occurred in Q3 2016, reducing 537,278 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's HCA Healthcare (HCA) Holding Value Over Time
Track share changes against reported price movement
Quarterly HCA Healthcare (HCA) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +126,943 | Add 0.00% | 126,942 | $36.06 |
| Q3 2013 | -68,188 | Reduce 53.72% | 58,754 | $42.75 |
| Q4 2013 | +80,245 | Add 136.58% | 138,999 | $47.71 |
| Q1 2014 | -105,445 | Reduce 75.86% | 33,554 | $52.51 |
| Q2 2014 | -8,336 | Reduce 24.84% | 25,218 | $56.39 |
| Q3 2014 | -21,519 | Reduce 85.33% | 3,699 | $70.56 |
| Q4 2014 | -3,699 | Sold Out | 3,699 | $0.00 |
| Q2 2015 | +25,396 | New Buy | 25,396 | $90.72 |
| Q3 2015 | -25,396 | Sold Out | 25,396 | $0.00 |
| Q4 2015 | +247,339 | New Buy | 247,339 | $67.63 |
| Q1 2016 | +374,893 | Add 151.57% | 622,232 | $78.05 |
| Q2 2016 | +294,438 | Add 47.32% | 916,670 | $77.01 |
| Q3 2016 | -537,278 | Reduce 58.61% | 379,392 | $75.63 |
| Q4 2016 | -262,448 | Reduce 69.18% | 116,944 | $74.02 |
| Q1 2017 | +208,745 | Add 178.50% | 325,689 | $88.99 |
| Q2 2017 | +13,650 | Add 4.19% | 339,339 | $87.20 |
| Q3 2017 | -11,763 | Reduce 3.47% | 327,576 | $79.59 |
| Q4 2017 | -327,576 | Sold Out | 327,576 | $0.00 |
| Q2 2018 | +104,824 | New Buy | 104,824 | $102.60 |
| Q3 2018 | +113,775 | Add 108.54% | 218,599 | $139.12 |
| Q4 2018 | -5,305 | Reduce 2.43% | 213,294 | $124.45 |
| Q1 2019 | +36,176 | Add 16.96% | 249,470 | $130.38 |
| Q2 2019 | -238,777 | Reduce 95.71% | 10,693 | $135.14 |
| Q3 2019 | -10,693 | Sold Out | 10,693 | $0.00 |
| Q4 2019 | +15,562 | New Buy | 15,562 | $147.80 |
| Q1 2020 | +26,957 | Add 173.22% | 42,519 | $89.84 |
| Q2 2020 | -25,802 | Reduce 60.68% | 16,717 | $97.09 |
| Q3 2020 | +15,554 | Add 93.04% | 32,271 | $124.69 |
| Q4 2020 | -6,580 | Reduce 20.39% | 25,691 | $164.45 |
| Q1 2021 | +30 | Add 0.12% | 25,721 | $188.33 |
| Q2 2021 | +9,849 | Add 38.29% | 35,570 | $206.75 |
| Q3 2021 | -1,088 | Reduce 3.06% | 34,482 | $242.71 |
| Q4 2021 | +176 | Add 0.51% | 34,658 | $256.91 |
| Q1 2022 | -7,106 | Reduce 20.50% | 27,552 | $250.62 |
| Q2 2022 | -6,109 | Reduce 22.17% | 21,443 | $168.07 |
| Q3 2022 | -8,154 | Reduce 38.03% | 13,289 | $183.76 |
| Q4 2022 | +7,218 | Add 54.32% | 20,507 | $239.96 |
| Q1 2023 | +6,344 | Add 30.94% | 26,851 | $263.68 |
| Q2 2023 | -3,088 | Reduce 11.50% | 23,763 | $303.48 |
| Q3 2023 | +565 | Add 2.38% | 24,328 | $245.98 |
| Q4 2023 | -10,018 | Reduce 41.18% | 14,310 | $270.68 |
| Q1 2024 | +8,849 | Add 61.84% | 23,159 | $333.53 |
| Q2 2024 | -1,053 | Reduce 4.55% | 22,106 | $321.28 |
| Q3 2024 | +224 | Add 1.01% | 22,330 | $406.43 |
| Q4 2024 | -924 | Reduce 4.14% | 21,406 | $300.15 |
| Q1 2025 | -13,524 | Reduce 63.18% | 7,882 | $345.55 |
| Q2 2025 | -460 | Reduce 5.84% | 7,422 | $383.10 |
| Q3 2025 | +16,193 | Add 218.18% | 23,615 | $426.20 |
Joel Greenblatt's HCA Healthcare Investment FAQs
Joel Greenblatt first purchased HCA Healthcare, Inc. (HCA) in Q2 2013, acquiring 126,942 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held HCA Healthcare, Inc. (HCA) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to HCA Healthcare, Inc. (HCA) was in Q1 2016, adding 622,232 shares worth $48.56 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 23,615 shares of HCA Healthcare, Inc. (HCA), valued at approximately $10.06 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, HCA Healthcare, Inc. (HCA) represents approximately 0.04% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in HCA Healthcare, Inc. (HCA) was 916,670 shares, as reported at the end of Q2 2016. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.